Age-related real-world outcomes for patients (pts) with metastatic colorectal cancer (mCRC).

被引：0
|
作者：
Curtis, Melissa [1 ]
Nussbaum, Nathan Coleman [1 ]
Hamrick, Harvey J. [1 ]
Bennette, Caroline Savage [1 ]
Meropol, Neal J. [1 ]
Miksad, Rebecca A. [1 ]
机构：
[1] Flatiron Hlth, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.3613
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3613
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world treatment patterns and outcomes associated with bevacizumab (bev) in metastatic colorectal cancer (mCRC).
    Saverno, Kimberly
    Walker, Mark S.
    Hennessy, Daniel
    Dhawan, Ravinder
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Real world (RW) use and outcomes of regorafenib (REG) flexible dosing in patients (pts) with metastatic colorectal cancer (mCRC) in Europe
    Peeters, Marc
    Chibaudel, Benoist
    Barzi, Afsaneh
    Ostojic, Helene
    Pan, Xiaoyun
    Yasuda, Marie
    Chen, Chi-Chang
    Multani, Jasjit
    Casey, Vicky
    Vassilev, Zdravko
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 47 - 47
  • [3] Real-world evidence (RWE) on the clinical outcomes in 1st-line chemotherapy (CT) for fit and vulnerable patients (pts) with metastatic colorectal cancer (mCRC)
    Yamazaki, K.
    Yamanaka, T.
    Hamano, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S431 - S431
  • [4] Real-world (RW) study in patients (pts) with metastatic colorectal cancer (mCRC) with long-term responses to regorafenib in the USA.
    Kim, Richard D.
    Pan, Xiaoyun
    Ostojic, Helene
    Zhang, Yiqiao
    Lunacsek, Orsolya
    Pisa, Federica
    Peeters, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 48 - 48
  • [5] A real-world application of liquid biopsy (LB) in metastatic colorectal cancer (mCRC).
    Procaccio, Letizia
    Del Re, Marzia
    Crucitta, Stefania
    Gianfilippo, Giulia
    Daniel, Francesca
    Di Antonio, Veronica
    Gallimberti, Sara
    Munari, Giada
    Zanella, Giulia
    Alberti, Giulia
    Rizzato, Mario Domenico
    Rasola, Cosimo
    Maddalena, Giulia
    Prete, Alessandra Anna
    Bergamo, Francesca
    Zagonel, Vittorina
    Lonardi, Sara
    Danesi, Romano
    Fassan, Matteo
    Loupakis, Fotios
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [6] Impact of genomic alterations (GAs) on outcomes and their distribution by age groups in metastatic colorectal cancer (mCRC) patients (pts)
    Sahin, Ibrahim Halil
    Chen, Wanqi H.
    Chen, Zhengjia
    Akce, Mehmet
    Alese, Olatunji B.
    Shaib, Walid Labib
    El-Rayes, Bassel F.
    Wu, Christina
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [7] Real-world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer
    Xu, Ting
    Li, Jian
    Wang, Zhenghang
    Zhang, Xiaotian
    Zhou, Jun
    Lu, Zhihao
    Shen, Lin
    Wang, Xicheng
    CANCER MEDICINE, 2023, 12 (09): : 10473 - 10484
  • [8] REAL-WORLD TREATMENT PATTERNS, SEQUENCING, AND UNMET NEED IN METASTATIC COLORECTAL CANCER (MCRC)
    Desai, K.
    Shao, C.
    Li, S.
    Hair, G. M.
    Liu, L.
    Jain, R.
    Amonkar, M.
    VALUE IN HEALTH, 2024, 27 (06) : S183 - S183
  • [9] Age-related disparity in treatment outcome and adverse events among patients with metastatic colorectal cancer (mCRC).
    Meng, Lingbin
    Thapa, Ram
    Xie, Hao
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Real-world (RW) testing patterns of serum lactate dehydrogenase (LDH) and its prognostic value among patients (pts) with metastatic colorectal cancer (mCRC).
    Lenz, Heinz-Josef
    Lunacsek, Orsolya
    Ostojic, Helene
    Pan, Xiaoyun
    Dochy, Emmanuelle
    Vassilev, Zdravko
    Khan, Nasreen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 46 - 46
12345